null

Interactive Pathway Diagrams

Interactive Resource

Immune Signalling Pathway Explorer

Explore the immunology behind our In Vivo functional-grade antibody range. Each map is fully interactive — hover any molecule for detail and click it to jump straight to the matching Assay Genie antibody or ELISA kit. Colour-coded by protein class and built from validated targets, the collection spans checkpoint biology, co-stimulation, cell depletion, the tumour microenvironment, humoral immunity and the core signalling cascades — TCR, TLR, inflammasome, NK and JAK/STAT.

14 interactive pathways Every node links to a product In Vivo antibodies & ELISA kits Downloadable SVG
1

PD-1 / PD-L1 Immune Checkpoint

The inhibitory brake: PD-1 engaging PD-L1/PD-L2 recruits SHP-2 to shut down T-cell activation — and how blockade releases it.

PD-1PD-L1PD-L2CTLA-4LAG-3TIM-3
Explore pathway
2

T-Cell Co-Stimulation & Agonists

The accelerator: CD28-family and TNF-receptor co-stimulators that amplify T-cell responses, and the agonist antibodies that mimic them.

4-1BBCD40CD70ICOSCD28
Explore pathway
3

In Vivo Depletion Atlas

How depleting antibodies clear defined immune-cell subsets by ADCC, CDC and ADCP — with a click-through pick-list of targets.

CD4CD8CD19NK1.1Ly6GCD25
Explore pathway
4

Treg Suppression & IL-2 Axis

Regulatory T cells at work: the IL-2 sink, CTLA-4, IL-10/TGF-β, and JAK–STAT5→FOXP3 — plus the antibodies that deplete or disarm them.

CD25CTLA-4IL-2CD127FOXP3
Explore pathway
5

Myeloid / TAM & MDSC Reprogramming

The tumour microenvironment: CSF-1R and GM-CSF driving suppressive TAMs and MDSCs, versus agonist anti-CD40 M1 repolarisation.

CSF-1RLy6CLy6GCD40GM-CSF
Explore pathway
6

Cytokine Neutralisation Network

A map of the major cytokine axes — pro-inflammatory, Th2, immunosuppressive and T-cell-growth — and the In Vivo antibodies that block each.

IFN-γTNFIL-1IL-4IL-10TGF-β
Explore pathway
7

B-Cell Activation & Germinal Centre

T-dependent humoral immunity: Tfh help, BCR signalling, class-switch and affinity maturation, and the plasma- and memory-cell fate switch.

CD19B220CD40ICOSIL-4BCL6
Explore pathway
8

TIGIT / DNAM-1 / CD155 Axis

The PVR-family balance: activating DNAM-1 versus inhibitory TIGIT, CD96 and PVRIG competing for the same CD155/CD112 ligands.

CD155TIGITDNAM-1CD96PVRIG
Explore pathway
9

CD4 T-Helper Differentiation

How a naive CD4 T cell commits to Th1, Th2, Th17, iTreg or Tfh — each set by a polarising cytokine, a STAT and a master transcription factor.

Th1Th2Th17iTregTfh
Explore pathway
10

T-Cell Receptor (TCR) Signalling

The full activation cascade: TCR/CD3 and CD28 through ZAP-70 and LAT into the NFAT, NF-κB, AP-1 and PI3K/AKT arms — with every checkpoint and phosphatase brake.

CD3ZAP-70PLCγ1NFATNF-κBAP-1
Explore pathway
11

Toll-Like Receptor (TLR) & Innate Sensing

Surface and endosomal TLRs routing through MyD88 and TRIF to NF-κB and IRF3 — firing pro-inflammatory cytokines and type I interferon.

TLR4MyD88TRIFNF-κBIRF3IFN-β
Explore pathway
12

NLRP3 Inflammasome & Pyroptosis

The two-signal platform: priming and activation assembling NLRP3–ASC–caspase-1 to mature IL-1β/IL-18 and drive gasdermin-D pyroptosis.

NLRP3ASCCaspase-1GSDMDIL-1βIL-18
Explore pathway
13

NK Cell Activation & Cytotoxicity

The activating-versus-inhibitory balance — NKG2D, CD16 and DNAM-1 against KIR and NKG2A — deciding perforin/granzyme killing and IFN-γ release.

NKG2DCD16KIRNKG2APerforinIFN-γ
Explore pathway
14

Cytokine JAK/STAT Signalling

Six receptor complexes end-to-end — JAK1/2/3 and TYK2 driving STAT1–6 to the nucleus — with the SOCS, SHP and PIAS brakes that tune every cytokine.

JAK1JAK2TYK2STAT1STAT3SOCS
Explore pathway
Browse the full In Vivo functional-grade range
Low & ultra-low endotoxin antibodies for in vivo blocking, depletion and agonist studies.
Explore In Vivo Antibodies →